StockNews.AI
BON
StockNews.AI
134 days

BON Announces Breakthrough in the Bio-manufacturing Technology of Tea Pigments

1. BON achieved a 12-16% yield in bio-manufacturing tea pigments. 2. Tea pigments show high purity levels over 95%, enhancing health applications. 3. The global tea pigment industry is projected to exceed $12 billion by 2025. 4. CEO emphasizes strategic partnerships for innovative tea-based health products. 5. Market potential for tea pigments is strong in digestive and metabolic health.

5m saved
Insight
Article

FAQ

Why Bullish?

The significant technological breakthrough and market potential for tea pigments may drive BON's stock price up. Similar past advancements in bioengineering have led to substantial increases in stock valuations.

How important is it?

The article pertains specifically to BON's recent developments and market positioning, making its insights highly relevant. The discussion of industry growth and technological advancement presents a clear pathway for BON's future success.

Why Long Term?

As the application and commercialization of tea pigments expand, BON could see sustained revenue growth. Long-term partnerships will solidify its market position similar to trends observed in other biotech firms.

Related Companies

APHABAYRYTISHAINNTR
April 07, 2025 12:00 ET  | Source: Bon Natural Life Limited XI’AN, China, April 07, 2025 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), a leading bio-ingredient solution provider in the natural, health and personal care industry, announced between October 2024 to January 2025, our company achieved groundbreaking progress in the bio-manufacturing technology of tea pigments, attaining an industrial-leading yields rate of 12-16% while maintaining purity levels surpassing 95%. Demonstrating significant biological properties including lipid-lowering, blood glucose reduction, antioxidant effects, and anti-peptic ulcers, tea pigments exhibit broad applicability across multiple health sectors. This compound is identified as the most promising functional tea derivative since the commercialization of tea polyphenols, with particularly strong growth potential in digestive wellness and blood glucose applications. Based on data from the Tea Pigments Research Institute and market research institutions, the global tea pigment industry scale is expected to exceed $12 billion by 2025. Moreover, with the extremely abundant raw material sources derived from tea, this represents a potential blockbuster-level innovative application. Yongwei Hu, CEO & Chairman of Bon, stated, “Our company will actively pursue innovative formulations of tea pigments-based products targeting in innovative application of gastrointestinal and metabolic health through strategic partnerships. We are highly optimistic about the prospects for collaboration with forward-thinking entities in nutrition science and preventive healthcare to accelerate market development of next-generation tea-based solutions.” 1Data from 2025-2030 China Tea Pigments Industry Development Research Report About Bon Natural Life Limited ("BON") BON is a Cayman Islands company engaged in the business of natural, health, and personal care industries. For more information, please visit the Company’s website at http://www.bnlus.com. For more information, please contact: Cindy Liu | IR Email: bonnatural@appchem.cn Safe Harbor Statement This press release contains certain statements that may include "forward-looking statements." All statements other than statements of historical fact included herein are "forward-looking statements." These forward-looking statements are often identified by the use of forward-looking terminology such as "believes," "expects" or similar expressions, involve known and unknown risks and uncertainties. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, they do involve assumptions, risks, and uncertainties, and these expectations may prove to be incorrect. You should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company's actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including those discussed in the Company's periodic reports that are filed with the Securities and Exchange Commission and available on its website (http://www.sec.gov). All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these factors. Other than as required under the securities laws, the Company does not assume a duty to update these forward-looking statements.

Related News